Royce & Associates’s CONMED CNMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-30,000
| Closed | -$2.36M | – | 1008 |
|
|
2020
Q3 | $2.36M | Hold |
30,000
| – | – | 0.03% | 651 |
|
|
2020
Q2 | $2.16M | Hold |
30,000
| – | – | 0.02% | 653 |
|
|
2020
Q1 | $1.72M | Buy |
30,000
+1,000
| +3% | +$57.3K | 0.02% | 633 |
|
|
2019
Q4 | $3.24M | Hold |
29,000
| – | – | 0.03% | 594 |
|
|
2019
Q3 | $2.79M | Hold |
29,000
| – | – | 0.03% | 632 |
|
|
2019
Q2 | $2.48M | Sell |
29,000
-475
| -2% | -$40.7K | 0.02% | 675 |
|
|
2019
Q1 | $2.45M | Buy |
29,475
+52
| +0.2% | +$4.33K | 0.02% | 682 |
|
|
2018
Q4 | $1.89M | Buy |
29,423
+5,013
| +21% | +$322K | 0.02% | 747 |
|
|
2018
Q3 | $1.93M | Buy |
24,410
+24,130
| +8,618% | +$1.91M | 0.01% | 833 |
|
|
2018
Q2 | $20K | Buy |
280
+97
| +53% | +$6.93K | ﹤0.01% | 1122 |
|
|
2018
Q1 | $12K | Sell |
183
-59
| -24% | -$3.87K | ﹤0.01% | 1147 |
|
|
2017
Q4 | $12K | Buy |
242
+22
| +10% | +$1.09K | ﹤0.01% | 1147 |
|
|
2017
Q3 | $12K | Buy |
+220
| New | +$12K | ﹤0.01% | 1128 |
|
|
2015
Q4 | – | Sell |
-81,500
| Closed | -$3.89M | – | 1129 |
|
|
2015
Q3 | $3.89M | Hold |
81,500
| – | – | 0.02% | 705 |
|
|
2015
Q2 | $4.75M | Hold |
81,500
| – | – | 0.02% | 744 |
|
|
2015
Q1 | $4.12M | Sell |
81,500
-700
| -0.9% | -$35.3K | 0.02% | 784 |
|
|
2014
Q4 | $3.7M | Hold |
82,200
| – | – | 0.01% | 849 |
|
|
2014
Q3 | $3.03M | Hold |
82,200
| – | – | 0.01% | 922 |
|
|
2014
Q2 | $3.63M | Hold |
82,200
| – | – | 0.01% | 931 |
|
|
2014
Q1 | $3.57M | Hold |
82,200
| – | – | 0.01% | 950 |
|
|
2013
Q4 | $3.49M | Hold |
82,200
| – | – | 0.01% | 967 |
|
|
2013
Q3 | $2.79M | Hold |
82,200
| – | – | 0.01% | 993 |
|
|
2013
Q2 | $2.57M | Buy |
+82,200
| New | +$2.57M | 0.01% | 1015 |
|